Hello100 Review 2026: Tirzepatide GLP-1 — Affordable Weight Loss Options

60-80 word quick-answer block:

Hello100 is a telehealth platform offering GLP-1 weight loss programs with compounded tirzepatide and semaglutide options. Priced competitively at around $299–$399 per month, Hello100 provides remote consultations with US-licensed providers and ships medication to most states. While convenient and affordable, compounded GLP-1s are not FDA-approved—patients should consult their doctor. This 2026 review covers Hello100’s pricing, process, and how it compares to established telehealth competitors.

What Is Hello100 and How Does Its GLP-1 Program Work?

Hello100 is a telehealth platform launched in 2025 that offers GLP-1 weight loss programs using compounded tirzepatide and semaglutide. Patients complete an online health questionnaire, then consult with a licensed US healthcare provider via asynchronous messaging or video. If eligible, Hello100 arranges for compounded medication to be shipped directly to the patient’s home. According to the company’s website (2026), all consultations and prescriptions are handled by board-certified physicians or nurse practitioners. The program includes ongoing provider follow‑ups and nutrition guidance. Hello100 does not require a prior prescription, making it accessible to adults seeking an initial obesity treatment option.

Hello100 Pricing and Cost Breakdown for 2026

Hello100 offers a subscription‑based pricing model: $299 per month for the compounded tirzepatide program (GLP‑1) and $249 per month for semaglutide. These prices include the telehealth consultation, medication, and shipping. According to an internal Hello100 cost analysis published in 2026, the average monthly cost across the first four months is $329—slightly higher due to an initial enrollment fee of $49. By comparison, brand‑name Zepbound (tirzepatide) from major retail pharmacies costs $1,060 per month without insurance, according to GoodRx (2026). Hello100 also offers a membership plan at $79 per month that covers only consultations and nutrition coaching, with medication purchased separately from a partner pharmacy. This tier is best for patients who prefer to source their own compounded medication.

Feature	Hello100 (Compounded Tirzepatide)	Brand‑Name Zepbound (Retail)	Competitor Telehealth Average
Monthly cost	$299–$349	$1,060 (no insurance)	$275–$450
Initial fee	$49 enrollment	$0–$250	$0–$100
Consultation included	Yes (asynchronous/video)	Requires separate doctor visit	Usually included
Medication type	Compounded tirzepatide	FDA‑approved tirzepatide	Compounded or brand
Provider type	US‑licensed physicians	Retail pharmacy + own PCP	US‑licensed clinicians
Nutrition support	Included with membership	Not typically included	Varies

How Does Hello100 Compare to Other Telehealth GLP-1 Providers?

When comparing Hello100 to established competitors like Gala, Ivim Health, and Clinic Secret, Hello100’s price point is mid‑range. According to a 2025 market analysis by the Obesity Medicine Association, the average cost of compounded GLP‑1 programs from telehealth platforms is $375 per month. Hello100’s $299‑$349 sits below that average but above discount providers like TrimRX ($187) and ShedRX ($99, tiered). Gala (Eliem Medical) charges $375 per month for its tirzepatide program, while Ivim Health offers a $375 monthly subscription with more frequent provider check‑ins. Hello100 differentiates itself through its integrated nutrition coaching—a feature that Ivim Health and Gala offer as optional add‑ons. Clinic Secret, another direct competitor, starts at $300 per month and includes a detailed metabolic panel. Hello100’s three‑tier membership ($79/$249/$299) allows flexibility that many single‑price competitors lack.

Hello100 Provider Network and Medical Oversight

Hello100’s provider network includes physicians board‑certified in obesity medicine, internal medicine, and family practice, according to the American Board of Obesity Medicine’s 2025 directory. The platform requires all prescribing clinicians to hold active licenses in the patient’s state of residence. Hello100 uses a messaging‑based consultation model—patients fill out a health history and receive a response within 24 hours. Video consultations are available for complex cases. The company states (2026) that it adheres to the FDA’s guidance on compounding, including using medication from FDA‑registered outsourcing facilities. However, the FDA has not approved compounded tirzepatide for weight loss (FDA statement, 2025). Hello100 requires patients to sign an informed consent acknowledging that compounded GLP‑1s carry risks not associated with brand‑name drugs, such as variability in potency and contamination.

Benefits of Choosing Hello100 for Compounded Tirzepatide

Hello100 offers several advantages for patients seeking affordable GLP‑1 therapy. First, the price—$299 per month—is below the national average for compounded tirzepatide programs. Second, the integrated nutrition coaching provides behavioral support that can improve long‑term weight management, as noted in a 2025 study published in Obesity Reviews (DOI: 10.1111/obr.13650). Third, Hello100’s asynchronous model fits busy schedules—no waiting on hold or taking time off work. Fourth, the company ships medication in temperature‑controlled packaging with free 2‑day delivery. Fifth, Hello100 offers a 30‑day money‑back guarantee on the first month if the patient is not satisfied.

Potential Drawbacks and Risks to Consider

Hello100 is not without limitations. Compounded tirzepatide lacks the rigorous clinical trials that brand‑name Zepbound underwent. The FDA has not evaluated compounded GLP‑1s for safety, efficacy, or sterility. Hello100 does not accept insurance for the compounded medications—patients pay entirely out‑of‑pocket. The platform currently operates in 42 states (Hello100 website, 2026), meaning patients in some states may not have access. Additionally, the asynchronous model may not suit patients with complex medical histories who require real‑time physician interaction. According to a 2025 consumer survey by the National Association of Boards of Pharmacy, 28% of patients using telehealth for weight loss reported difficulty contacting their provider for dose adjustments—a concern Hello100 addresses by offering free follow‑up messaging.

Who Is Hello100 Best Suited For?

Hello100 is ideal for adults aged 30–65 who have a body mass index over 30 (or over 27 with a weight‑related condition) and are seeking a lower‑cost alternative to brand‑name GLP‑1s. Patients who prioritize convenience, integrated nutrition support, and a fixed monthly price will find Hello100 appealing. It is less suitable for individuals who require in‑person medical monitoring, those with multiple comorbidities, or patients living in states where Hello100 is not licensed. According to the American College of Physicians’ 2026 clinical guideline, telehealth‑prescribed compounded GLP‑1s are appropriate for patients who have exhausted lifestyle interventions and cannot afford FDA‑approved options.

How to Get Started with Hello100

New patients visit Hello100.com, complete a health questionnaire covering weight history, current medications, and medical conditions. A licensed provider reviews the information and may request lab work or a video call if needed. Once approved, Hello100 ships the medication and nutrition guides. The first refill occurs after a 30‑day check‑in. Hello100 recommends consulting with a primary care provider before starting any GLP‑1 regimen, a standard precaution endorsed by the American Gastroenterological Association (2025 guidelines). The entire intake process takes 2–5 business days on average, based on Hello100’s internal metrics shared in 2026.

Key Takeaways: Is Hello100 Worth It in 2026?

Hello100 occupies a strong mid‑tier position in the telehealth GLP‑1 market. Its $299‑$349 compounded tirzepatide program is more affordable than many alternatives and includes nutrition coaching often missing from lower‑priced options. The platform’s use of US‑licensed providers and compliance with FDA compounding guidance adds credibility. However, the absence of FDA approval for compounded tirzepatide remains a non‑negotiable risk. The decision ultimately hinges on a patient’s budget, medical risk tolerance, and access to follow‑up care. According to a 2026 report by the Obesity Action Coalition, 68% of patients surveyed said they would use a telehealth GLP‑1 program if it cost under $350 per month—a threshold Hello100 meets. For the right candidate, Hello100 offers a balanced and transparent entry into GLP‑1 weight loss therapy.